| Cytokines and chemokines involved in osteoarthritis pathogenesis V Molnar, V Matišić, I Kodvanj, R Bjelica, Ž Jeleč, D Hudetz, E Rod, ... International journal of molecular sciences 22 (17), 9208, 2021 | 421 | 2021 |
| Preliminary Analysis of COVID-19 Academic Information Patterns: A Call for Open Science in the Times of Closed Borders J Homolak, I Kodvanj, D Virag Scientometrics, 2687–2701, 2020 | 185 | 2020 |
| Widely available lysosome targeting agents should be considered as potential therapy for COVID-19 J Homolak, I Kodvanj International journal of antimicrobial agents 56 (2), 106044, 2020 | 85 | 2020 |
| Publishing of COVID-19 preprints in peer-reviewed journals, preprinting trends, public discussion and quality issues I Kodvanj, J Homolak, D Virag, V Trkulja Scientometrics 127, 1339-1352, 2021 | 64 | 2021 |
| The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 via pyrimidine depletion V Dembitz, B Tomic, I Kodvanj, JA Simon, A Bedalov, D Visnjic Journal of Biological Chemistry 294 (42), 15257-15270, 2019 | 25 | 2019 |
| Is galactose a hormetic sugar? An exploratory study of the rat hippocampal redox regulatory network J Homolak, A Babic Perhoc, A Knezovic, I Kodvanj, D Virag, ... Molecular Nutrition & Food Research 65 (21), 2100400, 2021 | 24* | 2021 |
| Nitrocellulose redox permanganometry: a simple method for reductive capacity assessment J Homolak, I Kodvanj, A Babić Perhoč, D Virag, A Knezovic, ... MethodsX, 2021 | 19* | 2021 |
| Repurposing a digital kitchen scale for neuroscience research: a complete hardware and software cookbook for PASTA D Virag, J Homolak, A Kodvanj, Ivan, Babić Perhoč, ... Scientific Reports, 2021 | 18 | 2021 |
| A hacked kitchen scale-based system for quantification of grip strength in rodents J Homolak, D Virag, I Kodvanj, I Matak, AB Perhoc, A Knezovic, JO Barilar, ... Computers in biology and medicine 144, 105391, 2022 | 9 | 2022 |
| 5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts V Dembitz, H Lalic, I Kodvanj, B Tomic, J Batinic, K Dubravcic, D Batinic, ... BMC Cancer, 2020 | 9 | 2020 |
| An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19 J Homolak, I Kodvanj, V Trkulja Clinical Drug Investigation, 2021 | 4 | 2021 |
| People exposed to proton‐pump inhibitors shortly preceding COVID‐19 diagnosis are not at an increased risk of subsequent hospitalizations and mortality: A nationwide matched … I Kodvanj, J Homolak, V Trkulja British journal of clinical pharmacology 89 (2), 787-831, 2023 | 3 | 2023 |
| World Health Organization (WHO) COVID-19 Database: WHO Needs It? I Kodvanj, J Homolak, D Virag, V Trkulja Preprints.org, 2020 | 3 | 2020 |
| Outpatients prescribed with fluvoxamine around the time of COVID-19 diagnosis are not at a reduced risk of unfavorable COVID-19 course compared to their non-prescribed peers … V Trkulja, I Kodvanj Authorea Preprints, 2022 | 2* | 2022 |
| Non-alcoholic components of Pelinkovac, a Croatian wormwood-based strong liquor, counteract the inhibitory effect of high ethanol concentration on catalase in vitro J Homolak, AB Perhoc, M Joja, I Kodvanj, K Toljan, D Virag BioRxiv, 2022.01. 07.475357, 2022 | 1 | 2022 |
| Immunoglobulin G glycome and severity of COVID-19: more likely a quantification of bias than a true association. A comment on Petrović et al., “Composition of the … V Trkulja, I Kodvanj, J Homolak Glycobiology, 2020 | 1 | 2020 |
| A suggested effect of air temperature on severity of COVID-19 in hospitalized patients by Kifer et al.(Effects of environmental factors on severity and mortality of COVID-19 … V Trkulja, I Kodvanj, J Homolak | 1 | 2020 |
| P1024 Switching to subcutaneous infliximab in week 6–the effect on mucosal healing and treatment persistence M Brinar, L Zlopasa, I Kodvanj, M Jelakovic, N Turk, D Grgic, ... Journal of Crohn's and Colitis 19 (Supplement_1), i1896-i1896, 2025 | | 2025 |
| P0497 Faecal Incontinence and Urgency in IBD Patients on Biologic Therapy in Remission: Prevalence and Risk Factors M Jelakovic, L Peretin, I Kodvanj, M Brinar, N Turk, D Grgic, A Kunovic, ... Journal of Crohn's and Colitis 19 (Supplement_1), i1033-i1033, 2025 | | 2025 |
| My friend MIROSLAV: A Hackable Open-Source Hardware and Software Platform for High-Throughput Rodent Activity Monitoring in the Home Cage D Virag, J Homolak, I Kodvanj, AM Vargantolić, A Babić Perhoč, P Meglić, ... bioRxiv, 2024.06. 25.600592, 2024 | | 2024 |
Jan HomolakDepartment of Pharmacology, University of Zagreb School of MedicineEmail verificata su mef.hr
